2 most recent filings and news items mentioning JADE. Updated every 60 seconds.
RestructuringJun 11, 2026Neutral
Aerovate Therapeutics, Inc. converted into a Nevada corporation and renamed Jade Biosciences, Inc. The corporate restructuring updates the company's governing documents and state of incorporation.
View filing at SEC.gov →
OfferingJun 4, 2026Neutral
Jade Biosciences launched an underwritten public offering of 10 million shares of common stock with an additional 1.5 million share overallotment option. The offering provides capital for the bioscience company and is led by major investment banks Jefferies, TD Securities, and UB
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.